In a rat model of the hepatopulmonary syndrome, miR-101 inhibited the JAK2/STAT3 signaling pathway by targeting JAK2, thereby inhibiting the proliferation of PMVECs. The gene discussed is JAK2; the disease is hepatopulmonary syndrome.